» Authors » Theresa Steeb

Theresa Steeb

Explore the profile of Theresa Steeb including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 526
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Reinhardt L, Steeb T, Mifka A, Berking C, Meier F
J Cancer Educ . 2023 Jun; 38(5):1667-1674. PMID: 37316753
In 2008, a nationwide skin cancer screening (SCS) program was implemented in Germany. However, participation rates remain low. YouTube videos on SCS might educate eligible persons to undergo SCS. Until...
12.
Koch E, Steeb T, Bender-Sabelkampf S, Busch D, Feustel J, Kaufmann M, et al.
J Clin Med . 2023 Jun; 12(11). PMID: 37298008
Background: Many treatments for actinic keratosis (AK) have been proven efficient in clinical trials. However, patients with AK may still experience unsatisfactory therapeutic outcomes in clinical practice. Objectives: To investigate...
13.
Steeb T, Wessely A, Heppt M, Erdmann M, Klug S, Berking C
Cancer Med . 2023 Apr; 12(9):10829-10839. PMID: 37062065
Background: The national skin cancer screening (SCS) was introduced in Germany in 2008. However, public awareness and participation rates remain low. There are no campaigns or target group-specific invitation strategies...
14.
Kaufmann M, Steeb T, Wessely A, Meyerolbersleben M, French L, Berking C, et al.
Med Sci Educ . 2023 Apr; 33(1):7-9. PMID: 37008444
The use of immunotherapies in clinical practice has significantly expanded treatment options and improved the prognosis of patients with advanced cancers over the past decade. We have developed a virtual...
15.
Petzold A, Steeb T, Wessely A, Koch E, Vera J, Berking C, et al.
Cancer Treat Rev . 2023 Mar; 115:102543. PMID: 36931146
Background: Distinct systemic treatments exist for metastatic uveal melanoma. Tebentafusp and combined immune checkpoint blockade (ICB) with ipilimumab plus anti-PD-1 antibodies are the most commonly used treatment options but their...
16.
Kaiser I, Pfahlberg A, Mathes S, Uter W, Diehl K, Steeb T, et al.
J Clin Med . 2023 Mar; 12(5). PMID: 36902763
Assessing the risk of bias (ROB) of studies is an important part of the conduct of systematic reviews and meta-analyses in clinical medicine. Among the many existing ROB tools, the...
17.
Muller K, Berking C, Voskens C, Heppt M, Heinzerling L, Koch E, et al.
Front Med (Lausanne) . 2023 Feb; 10:1089013. PMID: 36744147
Background: In melanoma, in-transit metastases characteristically occur at the lower extremity along lymphatic vessels. Objectives: The objective of this study was to evaluate conventional or three-dimensional photography as a tool...
18.
Steeb T, Brutting J, Reinhardt L, Hoffmann J, Weiler N, Heppt M, et al.
J Cancer Educ . 2022 Dec; 38(4):1264-1270. PMID: 36585570
Skin cancer patients increasingly search the internet to acquire disease-related information. However, information on the internet may be misleading. Recently, SKINFO has been launched, a website exclusively created for German-speaking...
19.
Reinhardt L, Steeb T, Harlass M, Brutting J, Meier F, Berking C
J Dtsch Dermatol Ges . 2022 Dec; 20(12):1641-1644. PMID: 36508362
No abstract available.
20.
Reinhardt L, Steeb T, Harlass M, Brutting J, Meier F, Berking C
J Dtsch Dermatol Ges . 2022 Dec; 20(12):1641-1644. PMID: 36464812
No abstract available.